Welcome to our dedicated page for Afya SEC filings (Ticker: AFYA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Afya's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Afya's regulatory disclosures and financial reporting.
Afya Ltd controller Welder Ferreira Santos reported routine equity compensation activity. On May 7, 2026, he exercised derivative awards for 5,739 Class A common shares and had 1,578 shares withheld in a tax-related disposition at $14.41 per share.
Following these transactions, he directly owned 39,161 Class A common shares. Footnotes explain that restricted stock units convert into common shares one-for-one, with 500 RSUs vesting on May 5, 2026 and additional RSUs scheduled to vest in 2027, 2028 and 2029, subject to continued service.
Afya Ltd executive Anibal Jose Grifo de Sousa reported equity compensation activity in the form of restricted stock units converting into Class A common shares. On May 7, 2026, he acquired 17,500 Class A shares through derivative exercises, while 4,813 shares were withheld to cover tax obligations at $14.41 per share. After the tax-withholding disposition, his direct holdings in Class A common shares were 62,687 shares.
The filing shows RSUs convert into common shares on a one-for-one basis. One RSU grant vested as to 1,500 shares on May 5, 2026, with the remaining RSUs scheduled to vest as to 3,000, 4,500 and 6,000 shares on the first day of May in 2027, 2028 and 2029, subject to his continued service. A separate RSU award fully vested on May 5, 2026, contributing to the exercised amounts.
Afya Limited delivered solid results for the three-month period ended March 31, 2026, with revenue of R$1,012,712 thousand, up from R$936,360 thousand a year earlier. Growth was driven mainly by higher tuition fees across its undergraduate and continuing education operations.
Operating income reached R$393,600 thousand and net income was R$261,763 thousand, compared with R$257,036 thousand in the prior-year period. Basic earnings per share rose to R$2.88, while diluted earnings per share were R$2.85.
Afya generated strong net cash from operating activities of R$466,796 thousand and ended the period with cash and cash equivalents of R$1,332,866 thousand. The company continued to return capital, approving dividends of R$307,377 thousand and repurchasing treasury shares for R$69,511 thousand, while maintaining loans and financing of R$2,124,512 thousand.
Afya Limited delivered steady growth in the first quarter of 2026, with revenue reaching R$1,012.7 million, up 8.2% from a year earlier, driven mainly by higher medical course prices, more non-medical undergrad students, the FUNIC acquisition and expansion in Continuing Education.
Adjusted EBITDA rose 4.0% to R$511.4 million, while the margin slipped to 50.5% from 52.5% as Afya increased spending in Continuing Education and Medical Practice Solutions to support its investment cycle. Net income grew 1.8% to R$261.8 million, and basic EPS improved to R$2.88.
Cash and cash equivalents climbed to R$1,332.9 million, and net debt excluding IFRS 16 fell to R$1,151.3 million, aided by strong operating cash flow and despite acquisitions, dividends and share repurchases. Afya reaffirmed its 2026 guidance, including revenue between R$3.95–4.10 billion and Adjusted EBITDA of R$1.7–1.8 billion, and highlighted a R$307.4 million dividend and ongoing buybacks.
Afya Ltd executive Anibal Jose Grifo de Sousa, V.P. Legal, Compliance & Government Relations, exercised stock options covering 19,000 Class A common shares at $11.83 per share. This option exercise converted derivative holdings into common stock and did not involve any open-market sale.
Following the transaction, he directly owns 50,000 Class A common shares. The related stock option for 19,000 shares, originally exercisable beginning on May 1, 2025 and expiring on May 1, 2028, now shows zero derivative shares remaining in this award.
Afya Ltd Vice President Junior Lelio de Souza exercised stock options to acquire 66,000 Class A common shares on April 22, 2026. The options had an exercise price of $11.83 per share. After these transactions, he directly holds 66,000 Class A common shares and 6,000 stock options.
Afya Ltd Controller Welder Ferreira Santos reported an open-market sale of 3,325 Class A common shares. The shares were sold at an average price of $15.90 per share. After this transaction, the insider directly holds 35,000 Class A common shares, indicating the sale represents a relatively small portion of their overall position.
Afya Ltd executive Anibal Jose Grifo de Sousa, VP Legal, Compliance and Government Relations, reported open-market sales of Class A common shares. On April 13, 2026, he sold a total of 14,000 shares in three transactions priced between $15.35 and $15.50 per share. Following these sales, he directly holds 31,000 Class A common shares.
Afya Ltd Vice President Junior Lelio de Souza reported an open-market sale of Class A common shares. On April 9, 2026, he sold 16,279 Class A Common Shares at a price of $14.53 per share, leaving him with 0 shares of this security held directly after the transaction.
Afya Ltd Chief Financial Officer sells shares in open-market trade. CFO Luis Andre Carpintero Blanco sold 10,000 Class A common shares of Afya Ltd in an open-market transaction at $15.20 per share. After this sale, he directly holds 51,103 Class A common shares.